Cold Sore Fever Blister Treatment
- Product NDC
- 55910-859
- 11-digit product format
- 559100859
- Labeler code
- 55910
- Product ID
- 55910-859_996190eb-34cd-4925-abf9-16277bcf41ad
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Docosanol
- Dosage form
- CREAM
- Route
- TOPICAL
- Labeler
- Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)
- Application
- ANDA212385
- Marketing category
- ANDA
- Marketing start
- 2023-12-31
- Marketing end
- 2028-02-28
- Substance
- DOCOSANOL
- Active strength
- 100 mg/g
- NDC exclude flag
- No
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Cold Sore Fever Blister Treatment
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| DOCOSANOL | 100 mg/g |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 9G1OE216XY |
| Rxcui | 797534 |
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 55910-859-07 | Cold Sore Fever Blister Treatment | 1 in 1 PACKAGE | CREAM | 1 | | 4 |
| 55910-859-07 | Cold Sore Fever Blister Treatment | 2 g in 1 TUBE | CREAM | 2 | | 4 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 55910-859 | COLD SORE FEVER BLISTER TREATMENT (DOCOSANOL) CREAM [DOLGENCORP, INC. (DOLLAR GENERAL & REXALL)] | 3 | Current NDC, 2 package rows | 20240315_5ecf678b-d08a-4082-9d01-4468865a94b2.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 55910-859-07 | 55910085907 | 1 TUBE in 1 PACKAGE (55910-859-07) / 2 g in 1 TUBE | 1 tube | 2023-12-31 | 2028-02-28 | No | No | Historical |